Concordance between Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements in Syncardia Total Artificial Heart Recipients Receiving Postoperative Anticoagulation with Unfractionated Heparin

被引：0
|
作者：
Vela, M. Monteagudo [1 ]
Bowles, C. [1 ]
Raj, B. [1 ]
Simon, A. [1 ]
机构：
[1] Harefield Hosp, Cardiothorac Transplantat & Mech Circulatory Supp, London, England
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2020年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1133
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [41] Determining Cause for Activated Partial Thromboplastin Time and Anti-Factor Xa Discordance in Mechanical Circulatory Support Patients on Heparin; Can Thromboelastogram Help?
    Volod, O.
    Lam, L.
    Robert, C.
    Moriguchi, J.
    Yur, J.
    Garcia, M.
    Zhou, J.
    Wilde, A.
    Czer, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S463 - S463
  • [42] IS ANTI-FACTOR XA MONITORING BETTER THAN ACTIVATED PARTIALTHROMBOPLASTIN TIME (APTT) IN ACHIEVING THERAPEUTIC RESPONSE TO UNFRACTIONATED HEPARIN?
    Manzanades, Yuri
    NURSING IN CRITICAL CARE, 2021, 26 : 30 - 31
  • [43] Comparing Activated Partial Thromboplastin Time and Heparin anti-Xa levels to monitor anticoagulant intensity of unfractionated heparin in Extracorporeal Membrane Oxygenation
    Dhillon, E.
    Laffan, M.
    Arachchillage, D. Jayakody
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 138 - 138
  • [44] Anti-Factor Xa and Activated Partial Thromboplastin Time Strategies for Heparin Dosing After HeartMate3 Left Ventricular Assist Device Implantation
    Feng, I.
    Kurlansky, P. A.
    Powley, T. R.
    Vinogradsky, A. V.
    Hynds, M. A.
    Yang, C. G.
    Hastie, J. M.
    Sutherland, L. D.
    Shih, H.
    Yuzefpolskaya, M.
    Colombo, P. C.
    Sayer, G. T.
    Naka, Y.
    Uriel, N.
    Takeda, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S389 - S389
  • [45] A comparison of red blood cell transfusion utilization between anti-activated factor X and activated partial thromboplastin monitoring in patients receiving unfractionated heparin
    Belk, K. W.
    Laposata, M.
    Craver, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2148 - 2157
  • [46] Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation
    Vandenbriele, C.
    Bhudia, N.
    Dhillon, E.
    Doyle, J.
    Laffan, M. A.
    Ledot, S.
    Morgan, C.
    Murfin, B.
    Passariello, M.
    Patel, B.
    Pepper, J.
    Price, S.
    Singh, S.
    Trimlett, R.
    Arachchillage, D. R. J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 358 - 358
  • [47] Xcitement for Xa: Clinical Nurse Specialist as Orchestrator for Implementation of an Organizational Transition From Partial Thromboplastin Time (PTT) to Anti-Factor Xa for Heparin Monitoring
    Howard, Molly
    CLINICAL NURSE SPECIALIST, 2015, 29 (02) : E38 - E38
  • [48] IMPROVING CLINICAL DECISION MAKING FOR HEPARINIZED PATIENTS WITH DISCORDANT ANTI-FACTOR XA ACTIVITY AND ACTIVATED PARTIAL THROMBOPLASTIN TIME.
    Gombar, Saurabh
    Krishnan, Anandi
    Zehnder, James
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 40 - 40
  • [49] The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa R.
    Hori, Yasuhiko
    Kobayashi, Yoshio
    CIRCULATION, 2020, 142
  • [50] Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-Factor Xa measurements in continuous-flow left ventricular assist device patients
    Ton, Van-Khue
    Eisenberger, Andrew
    Jennings, Douglas
    Colombo, Paolo C.
    Topkara, Veli K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1365 - 1367
12345